Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds. (Q45979106)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds. |
scientific article |
Statements
Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds (English)
Eiji Kimura
Eiji Honda
Masato Yoshikawa
Takashi Nakahata
Yasuko Terao
Atsuko Suzuki
Takayuki Kawai
Yuuichi Arakawa
Hiroyuki Ohta
Naoyuki Kanzaki
Hideyuki Nakagawa